Advanced or Metastatic Colorectal Cancer research hub

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

This study is testing a new drug, amivantamab, for advanced bowel cancer. It checks how well it works alone or with standard chemotherapy, and how safe it is. The study aims to find better ways to treat advanced bowel cancer.